Risk assessment of cerebral thrombosis after implantation of metal stent via cerebral vascular intervention
返回论文页
|更新时间:2023-12-18
|
Risk assessment of cerebral thrombosis after implantation of metal stent via cerebral vascular intervention
Journal of Chongqing Medical UniversityVol. 36, Issue 2, Pages: 197-200(2013)
作者机构:
1. 海南省安宁医院神经内科,海口,571100
2. 海南医学院附属医院神经内科,海口,571100
作者简介:
基金信息:
DOI:
CLC:
Published:2013,
扫 描 看 全 文
OU Xiaofan, RONG Qiongwen. Risk assessment of cerebral thrombosis after implantation of metal stent via cerebral vascular intervention. [J]. Journal of Chongqing Medical University 36(2):197-200(2013)
DOI:
OU Xiaofan, RONG Qiongwen. Risk assessment of cerebral thrombosis after implantation of metal stent via cerebral vascular intervention. [J]. Journal of Chongqing Medical University 36(2):197-200(2013)DOI:
Risk assessment of cerebral thrombosis after implantation of metal stent via cerebral vascular intervention
Objective:To discuss the risk of cerebral thrombosis after implantation of metal stent via cerebral vascular intervention. Methods:Clinical data of 87 patients who underwent implantation of metal stent via cerebral vascular intervention in our department during 2009-2010 were retrospectively summarized,and the postoperative conditions were followed for 2 years. Serum D-dimer level and platelet level were monitored. Risk factors of new cerebral infarction at acute,subacute and advanced stages were tested by single factor analysis and Logistic regression. Results:There were 11 cases(12.64%) with new cerebral infarction after metal stent implanta-tion,7 at acute and subacute stages while 4 at advanced stage. Not taking aspirin on schedule,renal dysfunction,history of heart stent disease,higher level of platelet aggregation were high risk factors of new cerebral infarction at acute and subacute stages(P<0.05 or P≈0.05),while hypertension,not taking aspirin on schedule,diabetes,hyperlipidemia were high risk factors of cerebral thrombosis for-mation at advanced stage(P<0.05). Failure to take aspirin on schedule was the independent risk factor at all stages. Conclusions:Regular using of anti-platelet aggregation therapy may reduce the risk of ischemic stroke after metal stent implantation via cerebral vascular intervention.